GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 133 filers reported holding GOSSAMER BIO INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $208,200 | -89.0% | 250,000 | -83.4% | 0.03% | -86.1% |
Q1 2023 | $1,893,611 | -50.7% | 1,502,866 | -15.2% | 0.24% | -58.6% |
Q4 2022 | $3,844,253 | -16.9% | 1,771,545 | +358.5% | 0.59% | -39.5% |
Q3 2022 | $4,628,000 | -76.5% | 386,349 | -83.6% | 0.98% | -80.6% |
Q2 2022 | $19,673,000 | +23.7% | 2,350,448 | +28.3% | 5.02% | -2.6% |
Q1 2022 | $15,908,000 | +38.3% | 1,832,704 | +80.2% | 5.16% | -16.1% |
Q4 2021 | $11,501,000 | – | 1,016,857 | – | 6.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |